Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine
Loading...
Date
2016
Journal Title
Journal ISSN
Volume Title
Publisher
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
Abstract
Cancer cells have altered metabolism compared to normal cells, including dependence on glutamine (GLN) for survival, known as GLN addiction. However, some cancer cell lines do not require GLN for survival and the basis for this discrepancy is not well understood. GLN is a precursor for antioxidants such as glutathione (GSH) and NADPH, and GLN deprivation is therefore predicted to deplete antioxidants and increase reactive oxygen species (ROS). Using diverse human cancer cell lines we show that this occurs only in cells that rely on GLN for survival. Thus, the preference for GLN as a dominant antioxidant source defines GLN addiction. We show that despite increased glucose uptake, GLN addicted cells do not metabolize glucose via the TCA cycle when GLN is depleted, as revealed by C-13-glucose labeling. In contrast, GLN independent cells can compensate by diverting glucose-derived pyruvate into the TCA cycle. GLN addicted cells exhibit reduced PDH activity, increased PDK1 expression, and PDK inhibition partially rescues GLN starvation-induced ROS and cell death. Finally, we show that combining GLN starvation with pro-oxidants selectively kills GLN addicted cells. These data highlight a major role for GLN in maintaining redox balance in cancer cells that lack glucose-dependent anaplerosis.
Description
This research was supported by funds from the British Columbia Cancer Foundation through generous donations from Team Finn and Ride to Conquer Cancer and from Prostate Cancer Canada-Movember Foundation Team grant T2013-1 (to PHS), and from the NIH (R01 CA157996) and Damon-Runyon Cancer Research Foundation (to RJD) and NIH (R00 AG045144, OHY). AC was funded by programme 2219 of The Scientific and Technological Research Council of Turkey. NMC was funded by the Canadian Institutes for Health Research through a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award.
Keywords
PYRUVATE-DEHYDROGENASE COMPLEX, TUMOR-SUPPRESSOR PTEN, OXIDATIVE STRESS, DNA-DAMAGE, C-MYC, METABOLISM, GROWTH, SURVIVAL, ROS, MECHANISM